News
April 10, 2009 - The results of the ZEST randomized controlled trial released at ACC 2009 showed the Cypher Sirolimus-eluting Coronary Stent significantly outperformed the Endeavor and Taxus Liberte in the key clinical outcomes of ischemia-driven target lesion revascularization (TLR) and stent thrombosis through one year.
April 10, 2009
News
Merck, Cardiome Sign License Agreement for Investigational Drug for Treatment of Atrial Fibrillation
April 10, 2009 - Merck & Co., Inc. and Cardiome Pharma Corp.
April 10, 2009
News
April 10, 2009 — Invatec has entered into a strategic distribution agreement with Cardiovascular Systems Inc. (CSI) under which CSI will distribute Invatec’s FDA-cleared percutaneous transluminal angioplasty (PTA) balloon catheter product line in the U.S.
April 10, 2009Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024Technology
April 20, 2009 - BioReference Laboratories Inc. is now offering next- generation sequencing testing for Dilated Cardiomyopathy (DCM) through its GeneDx laboratory.
April 10, 2009Technology
Amtelco’s RED ALERT Emergency Notification system can be used to send mass notifications via phone, PDAs, SMS, pager, FAX and e-mail in seconds.
April 09, 2009
Technology
Vioguard has developed the first self-disinfecting computer keyboard specifically designed to help reduce the spread of preventable infections.
April 09, 2009Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024Technology
April 9, 2009 - PQRST Global Technologies displayed its VITUS telecardiology platform to share data, images and ECGs this week at HIMSS 20009 in Chicago.
April 09, 2009
News
April 9, 2009 -Physicians can dramatically reduce the radiation dose delivered to patients undergoing coronary CT angiography in a "triple rule-out" protocol by simply using tube current modulation, according to a study performed at Thomas Jefferson University Hospital in Philadelphia, PA.
April 09, 2009Technology
April 9, 2009 - Epic showed its newly introduced cardiovascular module for its electronic medical record (EMR) this week at HIMSS 2009 in Chicago.
April 09, 2009Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023Technology
April 9, 2009 - A fundamental issue facing healthcare worldwide is tying fragmented information and data silos together to increase intelligence, and Initiate Interoperable Health solutions showcased its vendor-neutral “middleware” to bridge disparate data during HIMSS 2009 in Chicago this week.
April 09, 2009News
April 9, 2009 – Vital Images recently announced the results of an independent survey of nearly 2,400 U.S. hospitals with more than 100 beds, which showed Vital Images continues to be the market share leader among 3D imaging vendors.
April 09, 2009
News
April 9, 2009 - Vital Images Inc. has achieved certification for Excellence in Service Operations by the Service & Support Professionals Association (SSPA), a certification benchmarked against industry best practices in a number of areas, including support operations, customer satisfaction, service sales and marketing, product serviceability, technology infrastructure and human resource systems.
April 09, 2009Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Technology
April 9, 2009 - Sage said its new Intergy Electronic Health Record (EHR) Version 5.5 allows for better medical device integration and auto-populates fields with information from many common cardiology devices. The company displayed the newest version of its EHR at HIMSS 2009 in Chicago this week.
April 09, 2009News
April 9, 2009 - According to research presented last week at ACC, patients with the CYP2C19*2 genotype had more ischemic events in the one year following percutaneous coronary intervention (PCI).
April 09, 2009News
April 9, 2009 - A successful randomized, double-blinded, placebo-controlled phase 2 clinical trial using an intramyocardial injection of a patient’s own CD34 stem cells as treatment for refractory angina has been completed, and included 22 centers across the U.S.
April 09, 2009© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now